Advertisement
Screener

Arbutus Biopharma Corp (ABUS) ROA

Arbutus Biopharma Corp (ABUS) ROA

  • 2026-06-30: ROA 55.85%.
  • 2026-03-31: ROA 57.99%.
  • 2025-12-31: ROA -35.41%.
  • 2025-09-30: ROA -43.27%.

Complete source-backed roa history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3055.85%
2026-03-3157.99%
2025-12-31-35.41%
2025-09-30-43.27%
2025-06-30-52.54%
2025-03-31-65.44%
2024-12-31-53.09%
2024-09-30-54.61%
2024-06-30-48.17%
2024-03-31-49.49%
2023-12-31-50.45%
2023-09-30-47.57%
2023-06-30-41.25%
2023-03-31-36.62%
2022-12-31-35.54%
2022-09-30-33.78%
2022-06-30-32.63%
2022-03-31-31.93%
2021-12-31-37.29%
2021-09-30-43.46%
2021-06-30-52.86%
2021-03-31-45.31%
2020-12-31-46.50%
2020-09-30-54.43%
2020-06-30-138.39%
2020-03-31-140.66%
2019-12-31-145.66%
2019-09-30-137.84%
2019-06-30-53.81%
2019-03-31-36.91%
2018-12-31-31.33%
2018-09-30-30.45%
2018-06-30-22.33%
2018-03-31-30.82%
2017-12-31-35.59%
2017-09-30-111.40%
2017-06-30-107.88%
2017-03-31-144.30%
2016-12-31-139.23%
2016-09-30-33.48%
2016-06-30-34.23%
2016-03-31-9.47%
2015-12-31-8.81%
2015-09-30-8.58%
2015-06-30-5.38%
2015-03-31-4.17%
2014-12-31-32.86%
2014-09-30-28.20%
2014-06-30-24.66%
2014-03-31-23.38%
2013-12-31-23.64%

Annual ROA

DateROA
2025-12-31-35.41%
2024-12-31-53.09%
2023-12-31-50.45%
2022-12-31-35.54%
2021-12-31-37.29%
2020-12-31-46.50%
2019-12-31-145.66%
2018-12-31-25.04%
2017-12-31-35.59%
2016-12-31-139.23%
2015-12-31-8.81%
2014-12-31-32.86%
2013-12-31-19.61%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Apnimed, Inc. (APMD)United States$0.899B
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Savara Inc (SVRA)United States$1.044B-9.10
Theravance Biopharma, Inc. (TBPH)$0.885B16.40